About Karl Scheidt
Karl Scheidt is a Professor in the Department of Chemistry and Professor of Pharmacology in the Feinberg School of Medicine.
He is also the faculty director of ChemCore for the Robert H. Lurie Comprehensive Cancer Center. His research interests focus on developing efficient strategies to create new molecules with translational and clinical potential. As the founding Executive Director of the NewCures Accelerator, he is responsible for developing and leading strategies to build commercial value for therapeutic discoveries within Northwestern.
Our Group Members
Our group is a tight-knit community that thrives on the open exchange of ideas and discussion, fostering an environment of continual learning.
With diverse backgrounds, experiences, and training, the Scheidt Lab members are the core of a highly collaborative and engaging research environment, and we hold a strong emphasis on mentorship. Our team hails from all over the United States and abroad.
Our alumni hold positions in a variety of different industries and all around the world, ranging from academic to pharmaceuticals to consulting.
The work that they have pioneered has allowed us to continue the pushing the boundaries of what is possible with our research. Having been a part of the Scheidt Research Group at one point, they are an extension of the diverse community that we have here.
Research Assistant Professor Opening
We are seeking a Research Assistant Professor with expertise in chemical and molecular biology for a new translational chemistry laboratory.
Postdoctoral Researcher Openings
Interested in a postdoc in catalysis or translational chemistry?